Clinical Trials on Acute Graft vs Host Disease in United Kingdom
Total 7480 results
-
Cynata Therapeutics LimitedCompletedGraft vs Host DiseaseAustralia, United Kingdom
-
Novartis PharmaceuticalsCompletedCorticosteroid Refractory Acute Graft vs Host DiseaseGermany, Japan, Saudi Arabia, Turkey, United Kingdom, Spain, Canada, Italy, Australia, Austria, France, Korea, Republic of, Hong Kong, Israel, Netherlands, Russian Federation, Denmark, Greece, Taiwan, Norway, Czechia, Bulgaria
-
H. Lee Moffitt Cancer Center and Research InstituteGateway for Cancer ResearchCompletedGraft vs. Host DiseaseUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedGraft Vs Host DiseaseUnited States
-
AbgenixSangstat Medical CorporationCompletedGraft Vs Host DiseaseUnited States
-
National Cancer Institute (NCI)TerminatedGraft vs Host Disease | Graft-Versus-Host Disease | Chronic Graft vs. Host DiseaseUnited States
-
Regimmune CorporationCompletedGraft Vs Host Disease | Graft-versus-host-disease | Acute-graft-versus-host Disease | Prevention of aGVHDUnited States
-
Alpine Immune Sciences, Inc.TerminatedGraft Vs Host DiseaseUnited States
-
MallinckrodtPRA Health SciencesTerminatedAcute Graft-versus-Host DiseaseUnited States, Canada, Germany, United Kingdom, Australia, Austria, Belgium, Italy, France, Netherlands, Switzerland
-
Incyte CorporationTerminatedAcute Graft-versus-host DiseaseUnited States, Spain, France, Italy, United Kingdom, Germany
-
EVIVE BiotechnologyMemorial Sloan Kettering Cancer CenterCompletedAcute Graft vs Host DiseaseUnited States
-
Columbia UniversityIncyte CorporationTerminatedGraft Vs Host Disease | Steroid Refractory GVHDUnited States
-
SoligenixTerminatedAcute Gastrointestinal Graft vs Host DiseaseUnited States
-
Masonic Cancer Center, University of MinnesotaRecruitingAcute-graft-versus-host DiseaseUnited States
-
Jazz PharmaceuticalsCompletedAcute-graft-versus-host Disease | Graft-versus-host DiseaseUnited States, Belgium, United Kingdom, Greece, Germany, Spain, France, Italy, Austria, Canada, Bulgaria, Croatia, Poland, Portugal
-
Henry Ford Health SystemRecruiting
-
XenikosNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsTerminatedSteroid-Refractory Acute Graft Versus Host DiseaseUnited States, Belgium, Croatia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Genentech, Inc.TerminatedAcute Graft-versus-host DiseaseUnited States, Canada
-
Genentech, Inc.Completed
-
Alexion PharmaceuticalsTerminatedAcute Graft-Versus-Host Disease | GIGVHDUnited States, France
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbCompletedGVHD | Graft-versus-host-disease | GVHD, AcuteUnited States
-
Northwell HealthWithdrawnAcute GVH DiseaseUnited States
-
Astex Pharmaceuticals, Inc.TerminatedAcute Graft Versus Host DiseaseUnited States
-
University of Kansas Medical CenterRecruitingAcute Graft Versus Host DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedGraft-Versus-Host DiseaseUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingAcute Graft-versus-Host Disease | Allogeneic Stem Cell TransplantUnited States
-
AltruBio Inc.CompletedSteroid-refractory Acute Graft-versus-Host Disease | Treatment-refractory Acute Graft-versus-Host DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedGraft Versus Host DiseaseUnited States
-
Medical College of WisconsinTerminatedAcute Graft Versus Host DiseaseUnited States
-
M.D. Anderson Cancer CenterMallinckrodtCompletedGraft Versus Host DiseaseUnited States
-
Everett MeyerNational Cancer Institute (NCI)WithdrawnGraft Versus Host DiseaseUnited States
-
AbGenomics B.V Taiwan BranchTerminatedAcute Graft Versus Host DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedAcute Graft Versus Host DiseaseUnited States
-
M.D. Anderson Cancer CenterAmgenTerminatedAcute Graft Versus Host DiseaseUnited States
-
University of Michigan Rogel Cancer CenterCompletedAcute Graft Versus Host DiseaseUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedGraft-Versus-Host DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)TerminatedGraft-Versus-Host DiseaseUnited States
-
Leland MethenyWithdrawnGastro-Intestinal Acute Graft Versus Host Disease (GI-aGVHD)United States
-
Mesoblast, Inc.Quintiles, Inc.CompletedGrade B Acute Graft Versus Host Disease | Grade C Acute Graft Versus Host Disease | Grade D Acute Graft Versus Host DiseaseUnited States
-
EquilliumBiocon LimitedRecruitingGVHD | GVHD, Acute | aGVHD | Acute-graft-versus-host DiseaseUnited States
-
Mesoblast, Inc.CompletedGraft Versus Host DiseaseUnited States, Italy, Australia, Canada, Switzerland, United Kingdom
-
University of Michigan Rogel Cancer CenterCompletedGraft-Versus-Host DiseaseUnited States
-
Emory UniversityCURE FoundationCompletedAcute Graft Versus Host Disease | Chronic Graft Versus Host Disease | Graft Versus Host DiseaseUnited States
-
Jonsson Comprehensive Cancer CenterWithdrawnAcute Graft Versus Host Disease | Gastrointestinal Tract Acute Graft Versus Host Disease | Severe Gastrointestinal Tract Acute Graft Versus Host Disease | Steroid Resistant Gastrointestinal Tract Acute Graft Versus Host DiseaseUnited States
-
EquilliumBiocon LimitedRecruitingGraft Versus Host Disease | GVHD | aGVHD | Acute-graft-versus-host Disease | Acute GVHDUnited States, Korea, Republic of, Germany, Israel, Spain, Belgium, Italy, Australia, France, Canada, Portugal, New Zealand
-
Dana-Farber Cancer InstituteBayer; Genzyme, a Sanofi CompanyCompleted
-
XenikosNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsTerminatedSteroid-Refractory Acute Graft Versus Host DiseaseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnGraft-versus-host Disease PreventionUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyTerminated
-
Facet BiotechCompletedGraft vs Host DiseaseUnited States